Thomas McMann
speaker
627 appearances
5 recordings
1 series
first heard Jun 2026
last heard 27 Jul
Thomas McMann’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 5 in all, peaking in Jun 2026 with 3.
Appearances
Yeah, and and what are some of the the biggest changes uh that you've made for this year that that people can expect that that have been before?
Oh nice.
And uh you mentioned there the the the hot seat session.
I know that's something new and a a bit different.
What what are you hoping to to get out of that in terms of that session and and what will it spark?
Run and how how are you feeling about the the event?
And since last year, w what do you think has changed the most within the farmer service and and C DMO landscape?
Yeah, I think w we're we're seeing the exact same with within the space.
You know, CEOs are telling us that uh it's very much more partnership driven and transparent and the y the communication of issues and problems and really working together um to to uh to to solve issues.
Um and I think it is changing massively the mindset around it is a strategic alliance now and not just uh an outsource sort of provider.
wider and and I think it's it's great to see and I think the the amount of C DMOs that are growing expanding and you know that the amount that are attending CPHI you know in Europe and America's um I think is a great telling sign for for the for the market and particularly that space.
I know we we continue to hear a lot about supply chain resilience and and sort of outsourcing how are those pressures implicated
influencing the conversations at the event and that what you're bringing this year.
Yeah.
And there's an increasing demand as well, I think, on on integrated pharma services um rather than sort of standalone capabilities.
And are you seeing uh the pharma companies rethink what they want from an out from outsourcing partners?
And is that come across maybe in some of things you're hearing uh around the event?
Th the the C DMO market is getting incredibly competitive globally.
What do you think separates the companies that are succeeding from those struggling uh t to differentiate?
Yeah, and looking ahead, w what do you think will define the next phase of growth and competitiveness for C DMOs and pharma services?
Showing 581–600 of 627 · page 30 of 32
← Previous
Next →